Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib N-oxide is the N-oxide derivative of Gefitinib.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib N-oxide is the N-oxide derivative of Gefitinib. |
Targets&IC50 | Tyr1173 site (NR6wtEGFR cells):37 nM , Tyr992 site (NR6wtEGFR cells):37 nM |
Molecular Weight | 462.9 |
Formula | C22H24ClFN4O4 |
CAS No. | 847949-51-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gefitinib N-oxide 847949-51-3 Others Gefitinib Noxide Gefitinib N oxide inhibitor inhibit